NKTR
Nektar Therapeutics · Healthcare
SVP, COO and CFO Gil M Labrucherie sold $69K of Nektar Therapeutics
Sold$68,920
$3.95Price
17,448Shares
−5%Stake
What NKTR did after the filing
- The stock from Wed, May 18 open, $57.45
- −2.1%
- S&P 500, same days
- −5.1%
Measured over 30 trading days, to the Jul 1 close.
Traded Mon, May 16. Filed Tue, May 17, 5:32 PM ET, after the close. Returns use the May 18 open and the Jul 1 close. Not investment advice.